Search
Aligos Therapeutics Inc
ALGSAdd to Watchlist
5.650USD
-0.040-0.70%
Close 06/23, 16:00（ET）Quotes delayed by 15 min
34.96MMarket Cap
LossP/E TTM
Aligos Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-06-23The current valuation score of Aligos Therapeutics Inc is 7.68, ranking 193 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.58, which is -48.78% below the recent high of -0.30 and -920.96% above the recent low of -5.89.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
